Our top pick for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Aemetis, Inc is an oil & gas refining & marketing business based in the US. Aemetis shares (AMTX) are listed on the NASDAQ and all prices are listed in US Dollars. Aemetis employs 160 staff and has a trailing 12-month revenue of around USD$180.3 million.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Mobile users
Latest market close | USD$2.2 |
---|---|
52-week range | USD$0.3705 - USD$5.1 |
50-day moving average | USD$2.5028 |
200-day moving average | USD$2.246 |
Wall St. target price | USD$7.13 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | USD$-1.964 |
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.2 from 2020-11-16
1 week (2021-01-07) | -28.80% |
---|---|
1 month (2020-12-17) | -7.17% |
3 months (2020-10-16) | -41.95% |
6 months (2020-07-16) | 168.62% |
1 year (2020-01-16) | 155.81% |
---|---|
2 years (2019-01-16) | 154.34% |
3 years (2018-01-16) | 205.56% |
5 years (2016-01-15) | 2.28 |
Valuing Aemetis stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Aemetis's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Aemetis's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$7.4 million.
The EBITDA is a measure of a Aemetis's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | USD$180.3 million |
---|---|
Operating margin TTM | 1.51% |
Gross profit TTM | USD$12.7 million |
Return on assets TTM | 1.55% |
Return on equity TTM | 0% |
Profit margin | -15.97% |
Book value | $-6.52 |
Market capitalisation | USD$63.3 million |
TTM: trailing 12 months
There are currently 1.0 million Aemetis shares held short by investors – that's known as Aemetis's "short interest". This figure is 48.7% up from 696,716 last month.
There are a few different ways that this level of interest in shorting Aemetis shares can be evaluated.
Aemetis's "short interest ratio" (SIR) is the quantity of Aemetis shares currently shorted divided by the average quantity of Aemetis shares traded daily (recently around 1.5 million). Aemetis's SIR currently stands at 0.68. In other words for every 100,000 Aemetis shares traded daily on the market, roughly 680 shares are currently held short.
However Aemetis's short interest can also be evaluated against the total number of Aemetis shares, or, against the total number of tradable Aemetis shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aemetis's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Aemetis shares in existence, roughly 50 shares are currently held short) or 0.057% of the tradable shares (for every 100,000 tradable Aemetis shares, roughly 57 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Aemetis.
Find out more about how you can short Aemetis stock.
We're not expecting Aemetis to pay a dividend over the next 12 months.
Aemetis's shares were split on a 1:10 basis on 15 May 2014. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aemetis shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Aemetis shares which in turn could have impacted Aemetis's share price.
Over the last 12 months, Aemetis's shares have ranged in value from as little as $0.3705 up to $5.1. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aemetis's is 0.0976. This would suggest that Aemetis's shares are less volatile than average (for this exchange).
Aemetis, Inc. operates as a renewable fuels and bio-chemicals company in North America and India. The company focuses on the acquisition, development, and commercialization of various technologies that replace traditional petroleum-based products primarily through the conversion of ethanol and biodiesel plants into advanced bio refineries. It owns and operates an ethanol facility in the California Central Valley near Modesto; and a renewable chemical and advanced fuel production facility on the East Coast of India. The company sells biodiesel and refined glycerin to transport companies, resellers, distributors, and refiners through its sales force and independent sales agents, as well as to brokers who resell the product to end-users. It also produces ethanol; and wet distiller's grains, distiller's corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. In addition, it produces dairy biogas; and high-grade sanitizer alcohol and various feed products. The company was formerly known as AE Biofuels, Inc. and changed its name to Aemetis, Inc. in November 2011. Aemetis, Inc. was founded in 2005 and is headquartered in Cupertino, California.
Everything we know about the Vacasa IPO, plus information on how to buy in.
Everything we know about the William Penn Bancorp IPO, plus information on how to buy in.
Everything we know about the Landos Biopharma Inc IPO, plus information on how to buy in.
Everything we know about the First High-School Education Group Co Ltd IPO, plus information on how to buy in.
Everything we know about the Knowlton Development Corp IPO, plus information on how to buy in.
Steps to owning and managing SASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing SAIL, with 24-hour and historical pricing before you buy.
Steps to owning and managing SAF, with 24-hour and historical pricing before you buy.
Steps to owning and managing RDHL, with 24-hour and historical pricing before you buy.
Steps to owning and managing SBFG, with 24-hour and historical pricing before you buy.